Known generically as pioglitazone, Actos is a diabetes medication manufactured by Japanese pharmaceutical company, Takeda Pharmaceuticals. Actos gained U.S. Food and Drug Administration (FDA) approval in 2007 to treat type 2 diabetes mellitus.
In August 2011, the FDA issued a safety update concerning Actos and bladder cancer. The communication stated that a new version of the Actos drug label had been approved by the FDA. The drug label update included a warning about prolonged use of Actos, especially for more than one year, put patients at a higher risk of developing bladder cancer.
In a study published in the British Medical Journal in May 2012, researchers concluded that the use of Actos does increase the risk of bladder cancer, especially in those patients consuming higher dosages for longer periods of time. The researchers observed the risk of bladder cancer increase significantly in patients using Actos for more than two years.
Symptoms of bladder cancer are those affecting urinary health and function. The most common sign of bladder cancer is blood in the urine. Though the blood may sometimes be visible, it is possible that its presence can only be detected by microscope. Additionally, patients with bladder cancer may also experience painful and frequent urination.
If you have taken Actos in the past, or are currently taking the drug, and have noticed any of the symptoms mentioned above, it is important to immediately consult with your prescribing physician.
Discuss your case and legal options with a Carey Danis & Lowe Actos bladder cancer lawyer. Our initial consultations are free.
Carey Danis & Lowe Actos attorneys are highly experienced in handling personal injury claims and pharmaceutical litigation involving defective drugs. We work closely alongside medical experts and our clients to develop strong cases.
For more information about Actos and bladder cancer, and for assistance with filing an Actos bladder cancer lawsuit, contact Carey Danis & Lowe by phone at 800.721.2519, or by completing a confidential personal injury claim.